研报 | 泰国酿酒(Thai Beverage)全线烈酒-创纪录的季度

2020年2月17日

买入 (升级)

收盘价 SGD 0.785 | 预测DIV SGD 0.025

目标价 SGD 0.950 | 总回报 24.2%

摘要

收入在我们的预期之内,但盈利超出了预期。啤酒业务令人失望,但烈酒业务表现良好。

2020年一季度,烈酒部门净利润同比激增25%,原因是销量增加和利润率提高了。烈酒在集团的税后净利中占比84%。销量达到创纪录的8900万升。

啤酒销量令人失望。2020年一季度,Sabeco 的销量下滑6%,这是由于有关其所有权的某些传言所致。

我们将建议升级至买入评级。烈酒业务的销量和利润率均优于预期。Sabeco啤酒业务将在未来几个季度中复苏。我们将分类加总估值法派生的目标价提高至0.95新元 (先前目标价为0.80新元)。2020财年末的收益提高了6%。我们提高了对利润率的假设,并对NAB业务的盈利能力进行了建模


积极方面

烈酒业务的利润率扩张。2020年一季度的销量增长了4.2%。棕色烈酒的利润率和价格均有所提高,增长了6至7%。精选的棕色烈酒将于2019年12月至2020年2月期间提价。白酒的利润率部分地受到瓶子的变化而有所提高。由于上个季度的库存积压,缅甸的烈酒销量疲软,导致销量下降。

非酒精饮料(NAB) 实现逆袭。由于息税折旧摊销前利润(EBITDA)从-0.4% 大幅跃升至10.6%,致使利润率首次受到冲击。对传统渠道的关注,降低了广告和促销费用。SG&A 费用在今年一季度同比下降11%。

消极方面

Sabeco 啤酒的销量举步维艰。2020年一季度,Sabeco 的销量同比下降6%。这是由于某些假新闻的传播,打击了销量。在政府的新闻发布和有影响力人士的支持下,这一情况正在不断改善。国产啤酒表现良好,销量同比增长13.5%。

前景

我们对前景更为乐观。我们最初的担忧关注在泰国的消费支出上,尤其是农业收入。泰国的农业收入一直富有弹性,特别是在政府的支持下。烈酒不仅销量可观,消费者更在购买价格高昂,以及利润率更高的棕色烈酒。啤酒的销量令人失望,但我们预计,在度过了这段低谷后,销量将出现反弹。

Covid-19(新冠肺炎)的不幸爆发将抑制销量,特别是在贸易或店内消费的饮料方面。就泰国酿酒而言,啤酒最容易受到贸易消费的影响。另一类风险敞口是游客人数减少造成的销量损失。核心的棕色烈酒相对不受影响,因为消费主要是在家里和当地的消费者。

投资行动

通过分类加总估值法,升级至买入评级,派生的目标价为0.95新元。

我们正在升级评级建议,从减持升至买入。我们基于分类加总估值法派生的目标价上调至0.95新元 (先前目标价为0.80新元),这是因为2020财年末的收益提高了6%,以及低于同业的估值折扣。

本文为英文翻译版本,仅供参考,一切请以英文版本为准。如果有想了解更多全球股市资讯,请关注微信公众共 “辉立资本新加坡” (SGPSPL)。同时提供在线免费开设股票账户,一个账户轻松交易美股,港股,新加坡股,中国A股,越南股票,韩国股票,德国股票,马来西亚股票,泰国股票,印尼股票,菲律宾股票,日本股票,澳大利亚股票,台湾股票,加拿大股票,英国股票,法国股票,荷兰股票,葡萄牙股票,比利时股票,土耳其股票

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com